XML 122 R107.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Compensation - Summary of Nonvested Restricted Stock Unit Activity (Details)
12 Months Ended
Dec. 31, 2022
$ / shares
shares
Shares  
Non-vested outstanding, beginning balance (in shares) | shares 269,718
Granted (in shares) | shares 227,210
Vested (in shares) | shares (50,236)
Forfeited or cancelled (in shares) | shares (43,878)
Non-vested outstanding, ending balance (in shares) | shares 402,814
Weighted Average Grant Date Fair Value  
Non-vested outstanding, weighted average grant date fair value, beginning balance (in dollars per share) | $ / shares $ 15.97
Grants in period, weighted average exercise price (in dollars per share) | $ / shares 6.60
Vested in period, weighted average exercise price (in dollars per share) | $ / shares 14.89
Forfeited or cancelled in period, weighted average exercise price (in dollars per share) | $ / shares 13.93
Non-vested outstanding, weighted average grant date fair value, ending balance (in dollars per share) | $ / shares $ 11.04
Restricted Stock Units (RSUs)  
Shares  
Non-vested outstanding, beginning balance (in shares) | shares 117,109
Granted (in shares) | shares 97,808
Vested (in shares) | shares (50,236)
Forfeited or cancelled (in shares) | shares (17,129)
Non-vested outstanding, ending balance (in shares) | shares 147,552
Weighted Average Grant Date Fair Value  
Non-vested outstanding, weighted average grant date fair value, beginning balance (in dollars per share) | $ / shares $ 15.53
Grants in period, weighted average exercise price (in dollars per share) | $ / shares 6.67
Vested in period, weighted average exercise price (in dollars per share) | $ / shares 14.89
Forfeited or cancelled in period, weighted average exercise price (in dollars per share) | $ / shares 13.43
Non-vested outstanding, weighted average grant date fair value, ending balance (in dollars per share) | $ / shares $ 10.12
Market-Based Stock Units (MSUs)  
Shares  
Non-vested outstanding, beginning balance (in shares) | shares 50,861
Granted (in shares) | shares 64,709
Vested (in shares) | shares 0
Forfeited or cancelled (in shares) | shares (9,854)
Non-vested outstanding, ending balance (in shares) | shares 105,716
Weighted Average Grant Date Fair Value  
Non-vested outstanding, weighted average grant date fair value, beginning balance (in dollars per share) | $ / shares $ 13.92
Grants in period, weighted average exercise price (in dollars per share) | $ / shares 6.04
Vested in period, weighted average exercise price (in dollars per share) | $ / shares 0
Forfeited or cancelled in period, weighted average exercise price (in dollars per share) | $ / shares 11.67
Non-vested outstanding, weighted average grant date fair value, ending balance (in dollars per share) | $ / shares $ 9.31
Performance Stock Units (PSUs)  
Shares  
Non-vested outstanding, beginning balance (in shares) | shares 101,748
Granted (in shares) | shares 64,693
Vested (in shares) | shares 0
Forfeited or cancelled (in shares) | shares (16,895)
Non-vested outstanding, ending balance (in shares) | shares 149,546
Weighted Average Grant Date Fair Value  
Non-vested outstanding, weighted average grant date fair value, beginning balance (in dollars per share) | $ / shares $ 17.50
Grants in period, weighted average exercise price (in dollars per share) | $ / shares 7.04
Vested in period, weighted average exercise price (in dollars per share) | $ / shares 0
Forfeited or cancelled in period, weighted average exercise price (in dollars per share) | $ / shares 15.76
Non-vested outstanding, weighted average grant date fair value, ending balance (in dollars per share) | $ / shares $ 13.17